Skip to content

California · Nonprofit

SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE

SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE (California) receives grants from 1 organization whose IRS filings report $200,000 to it, the largest being KURE IT INC ($200,000). 1 of them have funded it in more than one year.

Revenue FY2022
$108k
Funders on record
1
Grants received
$200k
Net assets
$0
1/1 repeat funderspeak grant-dependency 100%
01What it does

What Southern California Genitourinary Cancer Research Collaborative does

Mission

Southern California Genitourinary Cancer Research Collaborative (scgcrc) purpose was to promote and foster collaboration and improve patient care among clinical and translational researchers in southern california focused on genitourinary cancers. We intended to accomplish this by creating the first consortium for genitourinary cancer research physicians and research clinicians allowing them to collaborate and discuss trends in the industry and identify areas for collaboration.

As stated on its FY2022 Form 990-EZ.

Program

  1. Scgcrc held two board meetings in 2022. The first meeting was productive and we discussed various ways to collaborate as we emerged in a post-covid world. We received an educational presentation from board members and the team begin to collaborate on different ways to share and discuss data across multiple institutions. .about mid-year we determined that scgcrc could be better served and have a more dynamic future if we brought our resources and aligned with city of hope. The board voted to dissolve late in the year and distribute all remaining assets (after paying off all known debts and obligations) to city of hope. Substantially all remaining assets were distributed by end of february 2023. See schedule n for more details. .note that compensation paid to the executive director and program manager includes services provided both in 2021 and 2022.

    $107,922 spentof which $79,517 as grants
    100% of program spending

The program described on its FY2022 Form 990-EZ. Program spending in total: $107,922.

02The organization over time

Leadership and staff

Chief executive

Shailey Patel-See Part Iii Line 28

Board member, executive director

As listed on its FY2022 Form 990-EZ.

03Who funds it

Who funds it, year by year

2022 → 2023: the base held at 1 funder, grant income fell $108k → $93k.

Funder
'22
'23
total
Kure It Incunclassified
$200k
funders
1
1

From the IRS filings of SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

100% of SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE's grant income comes from California funders.

CA

In-state vs out-of-state, by year

’22
’23
California out of state home

Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Organizations like SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In California

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Footprint & structure

Files a return copy in 1 state

CA

Screen this organization

A dated, signed PDF of the compliance screen for SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE?
SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE (California) receives grants from 1 organization whose IRS filings report $200,000 to it, the largest being KURE IT INC ($200,000). 1 of them have funded it in more than one year.
How many funders does SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE have?
IRS filings report 1 organization giving $200,000 in grants to SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE, 1 of which have funded it in more than one year.
Who is the largest funder of SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE?
KURE IT INC is the largest funder on record, with $200,000 in grants. The full list of funders is on this page.
How can an organization like SOUTHERN CALIFORNIA GENITOURINARY CANCER RESEARCH COLLABORATIVE find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in California. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Southern California Genitourinary Cancer Research Collaborative →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2022 (financials across 2022–2022), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing